{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-246364","form_type":"8-K","ticker":"PLRX","cik":"0001746473","company_name":"PLIANT THERAPEUTICS, INC.","filed_at":"2022-09-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:56.891792+00:00","generated_at":"2026-06-23T09:09:17.723011+00:00","sec_items":["5.02","5.03","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Pliant Therapeutics appoints Katharine Knobil to Board, amends bylaws","bullets":["Dr. Katharine Knobil appointed to newly created Board seat; term expires at 2025 annual meeting.","Knobil will serve on R&D Committee; qualifies as independent director.","She receives option for 30,000 shares vesting over 3 years, annual retainer $39,000 prorated.","Board approved Second Amended and Restated Bylaws with enhanced shareholder proposal requirements and emergency procedures."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-246364","json":"https://secwatch.observer/filing/0001193125-22-246364.json","markdown":"https://secwatch.observer/filing/0001193125-22-246364.md","text":"https://secwatch.observer/filing/0001193125-22-246364.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1746473/000119312522246364/0001193125-22-246364-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1746473/000119312522246364/d400254d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T09:09:17.723011+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c255b520c3","claim":"Katharine Knobil was appointed as Director at PLIANT THERAPEUTICS, INC..","evidence_excerpt":"the Board of Directors (the “Board”) of Pliant Therapeutics, Inc. (the “Company”) appointed, upon the recommendation of the Nominating and Corporate Governance Committee of the Board, Dr. Katharine Knobil to fill a newly created Board seat","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1746473/000119312522246364/0001193125-22-246364-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}